U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07326904) titled 'Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease' on Dec. 17, 2025.
Brief Summary: The goal of this clinical trial was to evaluate the effectiveness and safety of fexuprazan 40 mg for relieving symptoms of gastroesophageal reflux disease (GERD) in adults. The study also compared fexuprazan with esomeprazole 40 mg, a commonly used treatment for GERD.
The main questions this study aimed to answer were:
* Did fexuprazan reduce GERD symptoms such as heartburn and acid regurgitation?
* Was fexuprazan safe and well tolerated compared with esomeprazole?
Researchers compared fexuprazan with eso...